nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—CYP1A1—chronic kidney failure	0.878	1	CbGaD
Thiabendazole—Lansoprazole—CYP2C18—chronic kidney failure	0.00361	0.414	CrCbGaD
Thiabendazole—Lansoprazole—CYP2C19—chronic kidney failure	0.00162	0.185	CrCbGaD
Thiabendazole—Lansoprazole—CYP1A1—chronic kidney failure	0.00161	0.185	CrCbGaD
Thiabendazole—Lansoprazole—CYP3A4—chronic kidney failure	0.00103	0.118	CrCbGaD
Thiabendazole—Lansoprazole—ABCB1—chronic kidney failure	0.000857	0.0982	CrCbGaD
Thiabendazole—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—chronic kidney failure	0.000664	0.00589	CbGpPWpGaD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—PTGS1—chronic kidney failure	0.000649	0.00576	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—FABP1—chronic kidney failure	0.000617	0.00548	CbGpPWpGaD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2C19—chronic kidney failure	0.000614	0.00544	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP2C19—chronic kidney failure	0.000605	0.00537	CbGpPWpGaD
Thiabendazole—CYP1A2—Estrogen metabolism—CYP1A1—chronic kidney failure	0.000604	0.00536	CbGpPWpGaD
Thiabendazole—CYP1A1—Tryptophan metabolism—CYP3A4—chronic kidney failure	0.0006	0.00532	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2C18—chronic kidney failure	0.0006	0.00532	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—CYP2C18—chronic kidney failure	0.000584	0.00518	CbGpPWpGaD
Thiabendazole—CYP1A2—Xenobiotics—CYP1A1—chronic kidney failure	0.000555	0.00492	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2B6—chronic kidney failure	0.000545	0.00483	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP2B6—chronic kidney failure	0.000537	0.00477	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ACAT1—chronic kidney failure	0.000535	0.00475	CbGpPWpGaD
Thiabendazole—CYP1A2—Tamoxifen metabolism—CYP1A1—chronic kidney failure	0.000534	0.00474	CbGpPWpGaD
Thiabendazole—CYP1A1—Tryptophan metabolism—CAT—chronic kidney failure	0.0005	0.00443	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP2C19—chronic kidney failure	0.000497	0.00441	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—SREBF2—chronic kidney failure	0.000492	0.00437	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—chronic kidney failure	0.000487	0.00432	CbGpPWpGaD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP3A4—chronic kidney failure	0.000485	0.0043	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—SREBF2—chronic kidney failure	0.000482	0.00427	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—chronic kidney failure	0.000479	0.00425	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidation by Cytochrome P450—CYP3A4—chronic kidney failure	0.000479	0.00425	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C18—chronic kidney failure	0.000472	0.00419	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP2C18—chronic kidney failure	0.000466	0.00413	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—LPL—chronic kidney failure	0.000463	0.00411	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—PTGS1—chronic kidney failure	0.000455	0.00403	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—CYP2C19—chronic kidney failure	0.000453	0.00401	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2B6—chronic kidney failure	0.000441	0.00391	CbGpPWpGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—EDN1—chronic kidney failure	0.00044	0.0039	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—PTGS1—chronic kidney failure	0.000414	0.00367	CbGpPWpGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—CYP1A1—chronic kidney failure	0.000412	0.00366	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—chronic kidney failure	0.000395	0.0035	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—CYP3A4—chronic kidney failure	0.000393	0.00349	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C19—chronic kidney failure	0.000391	0.00347	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—CPT1A—chronic kidney failure	0.000388	0.00344	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP2C19—chronic kidney failure	0.000386	0.00342	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—CYP3A4—chronic kidney failure	0.000383	0.00339	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C18—chronic kidney failure	0.000383	0.00339	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CPT1A—chronic kidney failure	0.000379	0.00336	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP2B6—chronic kidney failure	0.000368	0.00326	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP2B6—chronic kidney failure	0.000363	0.00322	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PRKAG2—chronic kidney failure	0.000355	0.00314	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—SREBF1—chronic kidney failure	0.000339	0.003	CbGpPWpGaD
Thiabendazole—CYP1A1—Melatonin metabolism and effects—NFKB1—chronic kidney failure	0.000334	0.00296	CbGpPWpGaD
Thiabendazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—chronic kidney failure	0.000332	0.00295	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—SREBF2—chronic kidney failure	0.000332	0.00294	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—SREBF1—chronic kidney failure	0.000332	0.00294	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—HMGCR—chronic kidney failure	0.00033	0.00292	CbGpPWpGaD
Thiabendazole—CYP1A1—Oxidative Stress—NFKB1—chronic kidney failure	0.000325	0.00288	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—HMGCR—chronic kidney failure	0.000323	0.00286	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP2C18—chronic kidney failure	0.000319	0.00283	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—CAT—chronic kidney failure	0.000319	0.00282	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C19—chronic kidney failure	0.000317	0.00281	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP2C18—chronic kidney failure	0.000314	0.00279	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—LPIN1—chronic kidney failure	0.000314	0.00278	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—chronic kidney failure	0.000309	0.00274	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—chronic kidney failure	0.000305	0.00271	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—LPL—chronic kidney failure	0.000295	0.00262	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—ABCA1—chronic kidney failure	0.000294	0.00261	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—chronic kidney failure	0.00029	0.00257	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—ABCA1—chronic kidney failure	0.000288	0.00255	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—chronic kidney failure	0.000285	0.00253	CbGpPWpGaD
Thiabendazole—CYP1A2—Tryptophan metabolism—CYP1A1—chronic kidney failure	0.000285	0.00253	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic kidney failure	0.000285	0.00253	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—RELA—chronic kidney failure	0.000274	0.00243	CbGpPWpGaD
Thiabendazole—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—chronic kidney failure	0.00027	0.00239	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—CYP1A1—chronic kidney failure	0.000267	0.00237	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—chronic kidney failure	0.000266	0.00236	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP2C19—chronic kidney failure	0.000264	0.00234	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1A—chronic kidney failure	0.000261	0.00232	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP2C19—chronic kidney failure	0.000261	0.00231	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—chronic kidney failure	0.000251	0.00222	CbGpPWpGaD
Thiabendazole—CYP1A1—Arachidonic acid metabolism—PTGS2—chronic kidney failure	0.000249	0.00221	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic kidney failure	0.000247	0.00219	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—FABP1—chronic kidney failure	0.000246	0.00218	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—PTGS1—chronic kidney failure	0.000242	0.00214	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP2B6—chronic kidney failure	0.000234	0.00208	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP2B6—chronic kidney failure	0.000231	0.00205	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—chronic kidney failure	0.000231	0.00205	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic kidney failure	0.000231	0.00204	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—SREBF1—chronic kidney failure	0.000229	0.00203	CbGpPWpGaD
Thiabendazole—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—chronic kidney failure	0.000228	0.00202	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—HMGCR—chronic kidney failure	0.000222	0.00197	CbGpPWpGaD
Thiabendazole—CYP1A1—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	0.000219	0.00194	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—FASN—chronic kidney failure	0.000218	0.00193	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ACAT1—chronic kidney failure	0.000213	0.00189	CbGpPWpGaD
Thiabendazole—CYP1A2—Melatonin metabolism and effects—NFKB1—chronic kidney failure	0.000213	0.00189	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—chronic kidney failure	0.00021	0.00186	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—CYP3A4—chronic kidney failure	0.000209	0.00185	CbGpPWpGaD
Thiabendazole—CYP1A1—Metapathway biotransformation—CYP3A4—chronic kidney failure	0.000206	0.00183	CbGpPWpGaD
Thiabendazole—CYP1A1—PPARA activates gene expression—PPARA—chronic kidney failure	0.000204	0.00181	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP2C18—chronic kidney failure	0.000203	0.0018	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP2C18—chronic kidney failure	0.000201	0.00178	CbGpPWpGaD
Thiabendazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—chronic kidney failure	0.000199	0.00177	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—ABCA1—chronic kidney failure	0.000198	0.00176	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic kidney failure	0.000192	0.00171	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—chronic kidney failure	0.000187	0.00166	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic kidney failure	0.00018	0.00159	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—chronic kidney failure	0.00018	0.00159	CbGpPWpGaD
Thiabendazole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—chronic kidney failure	0.000178	0.00158	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—RELA—chronic kidney failure	0.000175	0.00155	CbGpPWpGaD
Thiabendazole—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—chronic kidney failure	0.000172	0.00152	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—chronic kidney failure	0.00017	0.0015	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ABCG1—chronic kidney failure	0.000169	0.00149	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP2C19—chronic kidney failure	0.000168	0.00149	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP2C19—chronic kidney failure	0.000166	0.00147	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIP5K1B—chronic kidney failure	0.000165	0.00146	CbGpPWpGaD
Thiabendazole—CYP1A2—Arachidonic acid metabolism—PTGS2—chronic kidney failure	0.000159	0.00141	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—LCAT—chronic kidney failure	0.000158	0.0014	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic kidney failure	0.000158	0.0014	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—FABP1—chronic kidney failure	0.000157	0.00139	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—PTGS1—chronic kidney failure	0.000154	0.00137	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—chronic kidney failure	0.000147	0.00131	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PRKAG2—chronic kidney failure	0.000141	0.00125	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PRKD1—chronic kidney failure	0.000141	0.00125	CbGpPWpGaD
Thiabendazole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	0.000139	0.00124	CbGpPWpGaD
Thiabendazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—chronic kidney failure	0.000137	0.00122	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ACAT1—chronic kidney failure	0.000136	0.00121	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—chronic kidney failure	0.000134	0.00118	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP3A4—chronic kidney failure	0.000133	0.00118	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—SREBF2—chronic kidney failure	0.000132	0.00117	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP3A4—chronic kidney failure	0.000131	0.00117	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	0.000128	0.00113	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	0.000125	0.00111	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic kidney failure	0.000123	0.00109	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	0.000122	0.00109	CbGpPWpGaD
Thiabendazole—CYP1A1—Biological oxidations—POMC—chronic kidney failure	0.000116	0.00103	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—chronic kidney failure	0.000114	0.00102	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—chronic kidney failure	0.000114	0.00102	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—chronic kidney failure	0.000114	0.00101	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—FABP1—chronic kidney failure	0.000109	0.000971	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ABCG1—chronic kidney failure	0.000107	0.000953	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIP5K1B—chronic kidney failure	0.000105	0.000932	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	0.000104	0.000923	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AGXT—chronic kidney failure	0.000104	0.00092	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GATM—chronic kidney failure	0.000104	0.00092	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	0.000101	0.0009	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	0.000101	0.0009	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—LCAT—chronic kidney failure	0.000101	0.000896	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP1A1—chronic kidney failure	9.93e-05	0.00088	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP1A1—chronic kidney failure	9.79e-05	0.000868	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ACAT1—chronic kidney failure	9.49e-05	0.000842	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	9.37e-05	0.000831	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	9.28e-05	0.000823	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	9.1e-05	0.000807	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PRKAG2—chronic kidney failure	9e-05	0.000798	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PRKD1—chronic kidney failure	9e-05	0.000798	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	8.85e-05	0.000785	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MLXIPL—chronic kidney failure	8.83e-05	0.000783	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	8.66e-05	0.000768	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—SREBF2—chronic kidney failure	8.43e-05	0.000748	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	8.14e-05	0.000722	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC22A2—chronic kidney failure	8.07e-05	0.000716	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	7.97e-05	0.000707	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	7.89e-05	0.0007	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	7.81e-05	0.000692	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCG1—chronic kidney failure	7.5e-05	0.000665	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—POMC—chronic kidney failure	7.4e-05	0.000656	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIP5K1B—chronic kidney failure	7.34e-05	0.000651	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ARG2—chronic kidney failure	7.19e-05	0.000638	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LCAT—chronic kidney failure	7.06e-05	0.000626	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—FABP1—chronic kidney failure	6.98e-05	0.000619	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	6.64e-05	0.000589	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GATM—chronic kidney failure	6.62e-05	0.000587	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AGXT—chronic kidney failure	6.62e-05	0.000587	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—DDC—chronic kidney failure	6.48e-05	0.000574	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	6.47e-05	0.000574	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	6.47e-05	0.000574	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2B6—chronic kidney failure	6.29e-05	0.000558	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PRKAG2—chronic kidney failure	6.29e-05	0.000558	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PRKD1—chronic kidney failure	6.29e-05	0.000558	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	6.19e-05	0.000549	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ACAT1—chronic kidney failure	6.05e-05	0.000537	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	5.98e-05	0.00053	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	5.92e-05	0.000525	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SREBF2—chronic kidney failure	5.89e-05	0.000522	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	5.8e-05	0.000515	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GCKR—chronic kidney failure	5.69e-05	0.000504	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCC3—chronic kidney failure	5.69e-05	0.000504	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	5.64e-05	0.000501	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MLXIPL—chronic kidney failure	5.63e-05	0.000499	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LPIN1—chronic kidney failure	5.57e-05	0.000494	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	5.52e-05	0.00049	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	5.47e-05	0.000485	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LRP2—chronic kidney failure	5.45e-05	0.000484	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2C18—chronic kidney failure	5.45e-05	0.000484	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC22A2—chronic kidney failure	5.15e-05	0.000456	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	5.03e-05	0.000446	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCG1—chronic kidney failure	4.79e-05	0.000424	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIP5K1B—chronic kidney failure	4.68e-05	0.000415	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CPT1A—chronic kidney failure	4.64e-05	0.000411	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ARG2—chronic kidney failure	4.59e-05	0.000407	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LIPC—chronic kidney failure	4.52e-05	0.000401	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2C19—chronic kidney failure	4.52e-05	0.000401	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LCAT—chronic kidney failure	4.5e-05	0.000399	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	4.46e-05	0.000395	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SCARB1—chronic kidney failure	4.17e-05	0.00037	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTGS1—chronic kidney failure	4.13e-05	0.000366	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—DDC—chronic kidney failure	4.13e-05	0.000366	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	4.06e-05	0.00036	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SREBF1—chronic kidney failure	4.05e-05	0.000359	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PRKAG2—chronic kidney failure	4.01e-05	0.000356	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PRKD1—chronic kidney failure	4.01e-05	0.000356	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2B6—chronic kidney failure	4.01e-05	0.000356	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	3.95e-05	0.00035	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HMGCR—chronic kidney failure	3.94e-05	0.00035	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—FASN—chronic kidney failure	3.86e-05	0.000342	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	3.81e-05	0.000338	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SREBF2—chronic kidney failure	3.75e-05	0.000333	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCC3—chronic kidney failure	3.63e-05	0.000322	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GCKR—chronic kidney failure	3.63e-05	0.000322	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP3A4—chronic kidney failure	3.57e-05	0.000317	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	3.56e-05	0.000315	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LPIN1—chronic kidney failure	3.55e-05	0.000315	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCA1—chronic kidney failure	3.51e-05	0.000312	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	3.49e-05	0.000309	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LRP2—chronic kidney failure	3.48e-05	0.000308	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2C18—chronic kidney failure	3.48e-05	0.000308	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CAT—chronic kidney failure	2.97e-05	0.000264	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CPT1A—chronic kidney failure	2.96e-05	0.000262	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCB1—chronic kidney failure	2.89e-05	0.000257	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LIPC—chronic kidney failure	2.88e-05	0.000255	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2C19—chronic kidney failure	2.88e-05	0.000255	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	2.84e-05	0.000252	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LPL—chronic kidney failure	2.76e-05	0.000245	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SCARB1—chronic kidney failure	2.66e-05	0.000236	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTGS1—chronic kidney failure	2.63e-05	0.000234	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	2.59e-05	0.00023	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SREBF1—chronic kidney failure	2.58e-05	0.000229	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HMGCR—chronic kidney failure	2.51e-05	0.000223	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MTHFR—chronic kidney failure	2.48e-05	0.00022	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—FASN—chronic kidney failure	2.46e-05	0.000218	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PPARA—chronic kidney failure	2.44e-05	0.000216	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP3A4—chronic kidney failure	2.28e-05	0.000202	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	2.27e-05	0.000201	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCA1—chronic kidney failure	2.24e-05	0.000199	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—POMC—chronic kidney failure	1.99e-05	0.000176	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CAT—chronic kidney failure	1.9e-05	0.000168	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCB1—chronic kidney failure	1.84e-05	0.000164	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALB—chronic kidney failure	1.81e-05	0.000161	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LPL—chronic kidney failure	1.76e-05	0.000156	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NOS3—chronic kidney failure	1.73e-05	0.000154	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP1A1—chronic kidney failure	1.7e-05	0.000151	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTGS2—chronic kidney failure	1.58e-05	0.00014	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MTHFR—chronic kidney failure	1.58e-05	0.00014	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PPARA—chronic kidney failure	1.55e-05	0.000138	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—POMC—chronic kidney failure	1.27e-05	0.000112	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALB—chronic kidney failure	1.15e-05	0.000102	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NOS3—chronic kidney failure	1.1e-05	9.79e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTGS2—chronic kidney failure	1.01e-05	8.95e-05	CbGpPWpGaD
